US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 29, 2022 (4 years ago)

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: products were stored outside the drug label specifications.

What was recalled

Asthmanefrin Racephinephrine Inhalation Solution Bronchodilator, For temporary relief of mild symptoms of intermittent asthma, Preservative Free, Sterile, For Oral Inhalation Only, 30 vials per box, Nephron Pharmaceuticals Corporation, NDC 0487-2784-01.

Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
NDC code
0487-2784-01
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1324-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.